ABSTRACT
The present invention relates to an improved and industrially advantageous process for the preparation of 5-methyl-3-pyridine methanol or its salts of Formula I.
This compound is a key intermediate in the synthesis of Rupatadine, an antihistaminic agent.
Charges
0
14 March 2009
Bank Of India
5 Crore
24 October 2013
Bank Of India
2 Crore
07 September 2000
Uco Bank
1 Crore
03 December 1999
Uco Bank
80 Lak
14 March 2009
Others
0
03 December 1999
Uco Bank
0
07 September 2000
Uco Bank
0
24 October 2013
Bank Of India
0
14 March 2009
Others
0
03 December 1999
Uco Bank
0
07 September 2000
Uco Bank
0
24 October 2013
Bank Of India
0
Documents
Form AOC-4(XBRL)-12022021-signed
List of share holders, debenture holders;-28122020
Copy of MGT-8-28122020
Optional Attachment-(1)-28122020
Form MGT-7-28122020_signed
Form MGT-14-09122020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-09122020
Approval letter of extension of financial year of AGM-25112020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-25112020
Form MGT-14-27102020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-26102020
Optional Attachment-(2)-26102020
Optional Attachment-(4)-26102020
Optional Attachment-(1)-26102020
Optional Attachment-(3)-26102020
Form DPT-3-23102020_signed
Form MGT-14-20102020_signed
Form DIR-12-20102020_signed
Optional Attachment-(4)-19102020
Optional Attachment-(3)-19102020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-19102020